ARTICLE | Company News
Synsorb receives fast track for Synsorb Pk
March 13, 2000 8:00 AM UTC
Synsorb received fast track designation from the FDA for Synsorb Pk for the prevention of hemolytic uremic syndrome, a kidney disease associated with E. coli infections. The agent is in Phase III stud...